{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:44:15Z","timestamp":1787021055622,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010794","name":"Medicinska fakulteten, Ume\u00e5 Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Rep."],"DOI":"10.1186\/s41824-024-00236-2","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T18:01:26Z","timestamp":1736445686000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Primary staging with 2[18F]-FDG-PET\/CT and -PET\/MRI and radiotherapy response evaluation with MRI in uterine cervical cancer: an interim analysis of a prospective clinical trial"],"prefix":"10.1186","volume":"9","clinical-trial-number":[{"clinical-trial-number":"nct05855941","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Maja","family":"Aasa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lindquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika","family":"Ottander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0943-8178","authenticated-orcid":false,"given":"Sara N.","family":"Strandberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"issue":"1","key":"236_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s00259-014-2902-8","volume":"42","author":"K Beiderwellen","year":"2015","unstructured":"Beiderwellen K, Grueneisen J, Ruhlmann V, Buderath P, Aktas B, Heusch P et al (2015) [(18)F]FDG PET\/MRI vs. PET\/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results. Eur J Nucl Med Mol Imaging 42(1):56\u201365","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 1","key":"236_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/ijgo.13865","volume":"155Suppl 1","author":"N Bhatla","year":"2021","unstructured":"Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R (2021) Cancer of the cervix uteri: 2021 update. Int J Gynaecol Obstet 155Suppl 1(Suppl 1):28\u201344","journal-title":"Int J Gynaecol Obstet"},{"key":"236_CR3","unstructured":"Cancercentrum (2024) Nationellt v\u00e5rdprogram livmoderhals- och vaginalcancer [2024\u201301\u201325]. Available from: https:\/\/kunskapsbanken.cancercentrum.se\/diagnoser\/livmoderhals-och-vaginalcancer\/vardprogram\/"},{"issue":"5","key":"236_CR4","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1136\/ijgc-2023-004429","volume":"33","author":"D Cibula","year":"2023","unstructured":"Cibula D, Raspollini MR, Planchamp F, Centeno C, Chargari C, Felix A et al (2023) ESGO\/ESTRO\/ESP guidelines for the management of patients with cervical cancer: update 2023. Int J Gynecol Cancer 33(5):649\u2013666","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"236_CR5","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.radonc.2015.10.006","volume":"117","author":"S Das","year":"2015","unstructured":"Das S, Chandramohan A, Reddy JK, Mukhopadhyay S, Kumar RM, Isiah R et al (2015) Role of conventional and diffusion weighted MRI in predicting treatment response after low dose radiation and chemotherapy in locally advanced carcinoma cervix. Radiother Oncol 117(2):288\u2013293","journal-title":"Radiother Oncol"},{"issue":"4","key":"236_CR6","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1053\/j.sult.2019.03.001","volume":"40","author":"C Devine","year":"2019","unstructured":"Devine C, Viswanathan C, Faria S, Marcal L, Sagebiel TL (2019) Imaging and staging of cervical cancer. Semin Ultrasound CT MR 40(4):280\u2013286","journal-title":"Semin Ultrasound CT MR"},{"key":"236_CR7","unstructured":"Folkh\u00e4lsomyndigheten (2024) Vaccination mot humant papillomvirus (HPV) [2024-04-18]. Available from: https:\/\/www.folkhalsomyndigheten.se\/smittskydd-beredskap\/vaccinationer\/vacciner-som-anvands-i-sverige\/humant-papillomvirus-hpv\/"},{"issue":"6","key":"236_CR8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1053\/j.semnuclmed.2019.06.007","volume":"49","author":"N Gandy","year":"2019","unstructured":"Gandy N, Arshad MA, Park WE, Rockall AG, Barwick TD (2019) FDG-PET imaging in cervical cancer. Semin Nucl Med 49(6):461\u2013470","journal-title":"Semin Nucl Med"},{"issue":"12","key":"236_CR9","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1007\/s00259-015-3131-5","volume":"42","author":"J Grueneisen","year":"2015","unstructured":"Grueneisen J, Schaarschmidt BM, Heubner M, Aktas B, Kinner S, Forsting M et al (2015) Integrated PET\/MRI for whole-body staging of patients with primary cervical cancer: preliminary results. Eur J Nucl Med Mol Imaging 42(12):1814\u20131824","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"236_CR10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377\u2013381","journal-title":"J Biomed Inform"},{"key":"236_CR11","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L et al (2019) The REDCap consortium: building an international community of software platform partners. J Biomed Inform 95:103208","journal-title":"J Biomed Inform"},{"key":"236_CR12","doi-asserted-by":"publisher","first-page":"100883","DOI":"10.1016\/j.gore.2021.100883","volume":"38","author":"VN Harry","year":"2021","unstructured":"Harry VN, Persad S, Bassaw B, Parkin D (2021) Diffusion-weighted MRI to detect early response to chemoradiation in cervical cancer: a systematic review and meta-analysis. Gynecol Oncol Rep 38:100883","journal-title":"Gynecol Oncol Rep"},{"issue":"3","key":"236_CR13","first-page":"254","volume":"19","author":"B Khiewvan","year":"2016","unstructured":"Khiewvan B, Torigian DA, Emamzadehfard S, Paydary K, Salavati A, Houshmand S et al (2016) Update of the role of PET\/CT and PET\/MRI in the management of patients with cervical cancer. Hell J Nucl Med 19(3):254\u2013268","journal-title":"Hell J Nucl Med"},{"issue":"1","key":"236_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1148\/radiol.2019190088","volume":"292","author":"SI Lee","year":"2019","unstructured":"Lee SI, Atri M (2019) 2018 FIGO staging system for uterine cervical cancer: enter cross-sectional imaging. Radiology 292(1):15\u201324","journal-title":"Radiology"},{"issue":"7","key":"236_CR15","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1177\/0284185120943046","volume":"62","author":"LA Min","year":"2021","unstructured":"Min LA, Ackermans LL, Nowee ME, Griethuysen JJV, Roberti S, Maas M et al (2021) Pre-treatment prediction of early response to chemoradiotherapy by quantitative analysis of baseline staging FDG-PET\/CT and MRI in locally advanced cervical cancer. Acta Radiol 62(7):940\u2013948","journal-title":"Acta Radiol"},{"issue":"1","key":"236_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.radonc.2015.03.007","volume":"115","author":"D Minkoff","year":"2015","unstructured":"Minkoff D, Gill BS, Kang J, Beriwal S (2015) Cervical cancer outcome prediction to high-dose rate brachytherapy using quantitative magnetic resonance imaging analysis of tumor response to external beam radiotherapy. Radiother Oncol 115(1):78\u201383","journal-title":"Radiother Oncol"},{"key":"236_CR17","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s13014-015-0559-5","volume":"10","author":"JE Mongula","year":"2015","unstructured":"Mongula JE, Slangen BF, Lambregts DM, Cellini F, Bakers FC, Lutgens LC et al (2015) Consecutive magnetic resonance imaging during brachytherapy for cervical carcinoma: predictive value of volume measurements with respect to persistent disease and prognosis. Radiat Oncol 10:252","journal-title":"Radiat Oncol"},{"issue":"4","key":"236_CR18","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2967\/jnmt.120.247080","volume":"48","author":"NC Nguyen","year":"2020","unstructured":"Nguyen NC, Beriwal S, Moon CH, Furlan A, Mountz JM, Rangaswamy B (2020) (18)F-FDG PET\/MRI primary staging of cervical cancer: a pilot study with PET\/CT comparison. J Nucl Med Technol 48(4):331\u2013335","journal-title":"J Nucl Med Technol"},{"issue":"5","key":"236_CR19","doi-asserted-by":"publisher","first-page":"e0175401","DOI":"10.1371\/journal.pone.0175401","volume":"12","author":"J Nie","year":"2017","unstructured":"Nie J, Zhang J, Gao J, Guo L, Zhou H, Hu Y et al (2017) Diagnostic role of 18F-FDG PET\/MRI in patients with gynecological malignancies of the pelvis: a systematic review and meta-analysis. PLoS ONE 12(5):e0175401","journal-title":"PLoS ONE"},{"issue":"1","key":"236_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00259-017-3809-y","volume":"45","author":"T Sarabhai","year":"2018","unstructured":"Sarabhai T, Schaarschmidt BM, Wetter A, Kirchner J, Aktas B, Forsting M et al (2018) Comparison of (18)F-FDG PET\/MRI and MRI for pre-therapeutic tumor staging of patients with primary cancer of the uterine cervix. Eur J Nucl Med Mol Imaging 45(1):67\u201376","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"236_CR21","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.ijrobp.2018.06.014","volume":"102","author":"A Schernberg","year":"2018","unstructured":"Schernberg A, Bockel S, Annede P, Fumagalli I, Escande A, Mignot F et al (2018) Tumor shrinkage during chemoradiation in locally advanced cervical cancer patients: prognostic significance, and impact for image-guided adaptive brachytherapy. Int J Radiat Oncol Biol Phys 102(2):362\u2013372","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"236_CR22","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1007\/s00261-018-1665-2","volume":"43","author":"M Schwartz","year":"2018","unstructured":"Schwartz M, Gavane SC, Bou-Ayache J, Kolev V, Zakashansky K, Prasad-Hayes M et al (2018) Feasibility and diagnostic performance of hybrid PET\/MRI compared with PET\/CT for gynecological malignancies: a prospective pilot study. Abdom Radiol 43(12):3462\u20133467","journal-title":"Abdom Radiol"},{"key":"236_CR23","unstructured":"Socialstyrelsen (2024) Cancer i siffror [2024\u201301\u201325]. Available from: https:\/\/www.socialstyrelsen.se\/globalassets\/sharepoint-dokument\/dokument-webb\/statistik\/cancer-i-siffror-2023.pdf"},{"issue":"12","key":"236_CR24","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.3390\/cancers13122961","volume":"13","author":"P Sodeikat","year":"2021","unstructured":"Sodeikat P, Lia M, Martin M, Horn LC, H\u00f6ckel M, Aktas B et al (2021) The importance of clinical examination under general anesthesia: improving parametrial assessment in cervical cancer patients. Cancers 13(12):2961","journal-title":"Cancers"},{"key":"236_CR25","doi-asserted-by":"publisher","unstructured":"2018 FIGO Staging Classification for Cervical Cancer: Added Benefits of Imaging [Available from: https:\/\/doi.org\/10.1148\/rg.2020200013.","DOI":"10.1148\/rg.2020200013"},{"issue":"1","key":"236_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40644-020-00372-5","volume":"21","author":"A Steiner","year":"2021","unstructured":"Steiner A, Narva S, Rinta-Kiikka I, Hietanen S, Hynninen J, Virtanen J (2021) Diagnostic efficiency of whole-body (18)F-FDG PET\/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer. Cancer Imaging 21(1):16","journal-title":"Cancer Imaging"},{"issue":"7","key":"236_CR27","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1007\/s00330-013-2783-4","volume":"23","author":"MG Thomeer","year":"2013","unstructured":"Thomeer MG, Gerestein C, Spronk S, van Doorn HC, van der Ham E, Hunink MG (2013) Clinical examination versus magnetic resonance imaging in the pretreatment staging of cervical carcinoma: systematic review and meta-analysis. Eur Radiol 23(7):2005\u20132018","journal-title":"Eur Radiol"},{"issue":"2","key":"236_CR28","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3390\/diagnostics11020202","volume":"11","author":"H Tsuyoshi","year":"2021","unstructured":"Tsuyoshi H, Tsujikawa T, Yamada S, Okazawa H, Yoshida Y (2021) Diagnostic Value of (18)F-FDG PET\/MRI for revised 2018 FIGO staging in patients with cervical cancer. Diagnostics 11(2):202","journal-title":"Diagnostics"},{"issue":"4","key":"236_CR29","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.rpor.2013.04.026","volume":"18","author":"I Valduvieco","year":"2013","unstructured":"Valduvieco I, Biete A, Rios I, Llorente R, Rovirosa A, Pahisa J et al (2013) Correlation between clinical findings and magnetic resonance imaging for the assessment of local response after standard treatment in cervical cancer. Rep Pract Oncol Radiother 18(4):214\u2013219","journal-title":"Rep Pract Oncol Radiother"},{"issue":"1","key":"236_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.clinimag.2019.11.018","volume":"60","author":"M Virarkar","year":"2020","unstructured":"Virarkar M, Ganeshan D, Devine C, Bassett R Jr, Kuchana V, Bhosale P (2020) Diagnostic value of PET\/CT versus PET\/MRI in gynecological malignancies of the pelvis: a meta-analysis. Clin Imaging 60(1):53\u201361","journal-title":"Clin Imaging"},{"issue":"1","key":"236_CR31","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3390\/curroncol30010083","volume":"30","author":"M Virarkar","year":"2023","unstructured":"Virarkar M, Vulasala SS, Calimano-Ramirez L, Singh A, Lall C, Bhosale P (2023) Current update on PET\/MRI in gynecological malignancies-a review of the literature. Curr Oncol 30(1):1077\u20131105","journal-title":"Curr Oncol"},{"key":"236_CR32","unstructured":"World Health Organization (2024) Cervical cancer [2024-01-25]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cervical-cancer."},{"issue":"9","key":"236_CR33","first-page":"10536","volume":"13","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Shen B, Pei X, Liu H, Li G (2021) CT, MRI, and PET imaging features in cervical cancer staging and lymph node metastasis. Am J Transl Res 13(9):10536\u201310544","journal-title":"Am J Transl Res"}],"container-title":["EJNMMI Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41824-024-00236-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41824-024-00236-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41824-024-00236-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T11:05:46Z","timestamp":1744887946000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhi.springeropen.com\/articles\/10.1186\/s41824-024-00236-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["236"],"URL":"https:\/\/doi.org\/10.1186\/s41824-024-00236-2","relation":{},"ISSN":["3005-074X"],"issn-type":[{"value":"3005-074X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]},"assertion":[{"value":"29 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The PRODIGYN study (Prognostic and Diagnostic Added Value of Medical Imaging in Staging and Treatment Planning of Gynecological Cancer) was approved by the Swedish Ethical Review Authority with ethical approval number 2022-04207-01; NCT05855941. Study participants were given oral and written information and had the opportunity to ask questions. Written informed consent was obtained from all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all study participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}